Insulin Glargine Medication Template - ACTIVE LEARNING TEMPLATE PURPOSE OF MEDICATION Expected Pharmacological Action Complications Contraindications Precautions Interactions Medication Administration Evaluation of Medication Effectiveness Therapeutic Use Nursing Interventions Client Education Rebecca Grosse Insulin Glargine Basaglar Lantus
Control of hyperglycemia in diabetic patients Two nurses should check the insulin type dosage and expiration date Rotate injection sites May be injected SC intoabdominal wall thigh or upper arm This is the only insulin type that can be given IVas a direct dose or continuous infusion
Insulin Glargine Medication Template
Insulin Glargine Medication Template
Subcut Total insulin dose determined by needs of patient; generally 01 unit/kg/day;5070% of dose may be given as meal-related boluses of rapid-acting insulin, and the remainder as an intermediate or long-acting insulin. Assess patient for signs and symptoms of hypoglycemia and hyperglycemia periodically during therapy Monitor body weight .
ACTIVE LEARNING TEMPLATE PURPOSE OF MEDICATION Expected Pharmacological Action Complications Contraindications Precautions Interactions Medication Administration Evaluation of Medication Effectiveness Therapeutic Use Nursing Interventions Client Education insulin glargine hormone
Medication Template Regular Insulin ACTIVE LEARNING
Insulin glargine Lantus pancreatics Subcutaneous injectable Drug Drug Beta blockers clonidine and reserpine may mask some of the signs and symptoms of hypoglycemia Corticosteroids thyroid supplements estrogens isoniazid niacin phenothiazines and rifampin may insulin requirements
Insulin Glargine Medication Template
The expected pharmacological action ofinsulin is to lower blood glucose Insulin is generally administeredsubcutaneously It can beadministered via syringe insulinpen or subcutaneous pump Insulin syringe and peninjections should be rotatedbetween three sites ofadministration on the body
Insulin Glargine Medication Template
Insulin Glargine Medication Template
Medication Glargine ACTIVE LEARNING TEMPLATES Medication
ACTIVE LEARNING TEMPLATE Medication Bethany Shelton Insulin Glargine Lantus MEDICATION Exogenous
Insulin Glargine Medication Template
Insulin glargine is a synthetic version of human insulin that is FDA approved to treat adults and children with type 1 diabetes and adults with type 2 diabetes to improve and maintain glycemic control Insulin glargine is a long acting insulin injected once daily and provided a basal insulin level throughout the day
How it works Insulin glargine belongs to a drug class called long-acting insulins. A class of drugs is a group of medications that work in a similar way. These drugs are often used to.
Medication Template Insulin Lispro Humalog Studocu
Insulin glargine is a long acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours Insulin glargine is used to improve blood sugar control in people with diabetes mellitus Toujeo is for use in adults with type 1 or type 2 diabetes
Insulin Glargine Medication Template
Insulin Glargine Medication Template
Insulin Glargine Medication Template
Insulin glargine is a synthetic version of human insulin that is FDA approved to treat adults and children with type 1 diabetes and adults with type 2 diabetes to improve and maintain glycemic control Insulin glargine is a long acting insulin injected once daily and provided a basal insulin level throughout the day
Control of hyperglycemia in diabetic patients Two nurses should check the insulin type dosage and expiration date Rotate injection sites May be injected SC intoabdominal wall thigh or upper arm This is the only insulin type that can be given IVas a direct dose or continuous infusion
ATI Medication On Long Acting Insulin ACTIVE LEARNING TEMPLATES
ATI Insulin Lispro Humalog Med Sheet ACTIVE LEARNING TEMPLATES
Insulin Ati Medication Template
Insulin Medication Template
Regular Insulin Medication ATI Template ACTIVE LEARNING TEMPLATES